| Authors: |
Sabedot TS; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Malta TM; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Snyder J; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neuro Oncology, Henry Ford Health System, Detroit, Michigan, USA., Nelson K; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Wells M; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., deCarvalho AC; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Mukherjee A; Department of Pathology, Henry Ford Health System, Detroit, Michigan, USA., Chitale DA; Department of Pathology, Henry Ford Health System, Detroit, Michigan, USA., Mosella MS; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Sokolov A; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Asmaro KP; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Robin A; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Rosenblum ML; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Mikkelsen T; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Rock J; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Poisson LM; Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA., Lee I; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Walbert T; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neuro Oncology, Henry Ford Health System, Detroit, Michigan, USA., Kalkanis S; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Iavarone A; Institute for Cancer Genetics, Department of Pathology and Cell Biology, Department of Neurology, Columbia University Medical Center, New York, New York, USA., Castro AV; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Noushmehr H; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA. |
